Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins
- 1 March 1979
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 28 (3), 221-229
- https://doi.org/10.1016/0026-0495(79)90067-2
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Prevalence of serum lipid abnormalities in chronic hemodialysisMetabolism, 1977
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- Familial Hypercholesterolemia: A Genetic Defect in the Low-Density Lipoprotein ReceptorNew England Journal of Medicine, 1976
- Drug treatment of hyperlipidemiaAmerican Journal Of Medicine, 1976
- Differences among Hyperlipoproteinaemic Subjects in the Response of Lipoprotein Lipids to Resin TherapyEuropean Journal of Clinical Investigation, 1975
- The removal of cholesterol from aortic smooth muscle cells in culture and landschutz ascites cells by fractions of human high-density apolipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975
- Cholestyramine in Type II HyperlipoproteinemiaAnnals of Internal Medicine, 1973
- Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemiaJAMA, 1972
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971